A Clinical Trial for Post Traumatic Stress Disorder
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
he purpose of this study is to test whether a medication, called mifepristone (commonly known
as the ³Morning-After-Pill²), can help to prevent emotional problems after someone has
survived a traumatic experience. We are studying this medication for the treatment of
Post-traumatic Stress disorder (PTSD.